Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
The GlobalNewswire website noted that a new study has been released reporting that the growing adoption of open innovation models in pharmaceutical and biotechnology companies and increasing pharmaceutical outsourcing are the key factors driving the growth of the protein stability analysis market. The global protein stability analysis market is projected to reach USD 2,102.7 million in 2024 from USD 1,186.9 million in 2018. Pharmaceutical & biotechnology companies accounted for the largest share of the protein stability analysis market in 2018. The large share of this segment is primarily due to the extensive use of protein stability analysis in pharmaceutical & biotechnology companies for drug discovery applications.
Click here to read a summary of the study.